Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
OnCusp Therapeutics
OnCusp Therapeutics
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
OnCusp Therapeutics
Total Funding
$125 M
OnCusp Therapeutics Summary
Company Summary
Overview
OnCusp Therapeutics is a biopharmaceutical company that specializes in cancer treatment solutions. It focuses on developing bispecific antibodies, antibody-drug conjugates, and small-molecule therapies for the treatment of cancer.
Type
Private
Status
Active
Founded
2021
HQ
New York, NY, US
|
view all locations
Website
https://www.oncusptx.com/
Cybersecurity rating
Sectors
Healthcare
oncology
pharma
therapy
Homepage
Linkedin
Table of Contents
Key People
Locations
Competitors
Key People
Bing Yuan,
Co-Founder, Chairman, and CEO
Linkedin
Eric Slosberg,
Co-Founder, Chief Development Officer, and Head of Research and Development
Linkedin
Andy Fu,
Co-Founder, Chief Business Officer
Linkedin
Locations
View all
3 locations detected
New York, NY
HQ
United States
433 Broadway
Shanghai, Shang Hai Shi
China
989 ChangLe Road
Shanghai, Shang Hai Shi
China
Suite 802, No. 1576, West Nanjing Rd
Competitors and Similar Companies
Seagen
Healthcare - Subsidiary
Century Therapeutics
Healthcare - Public
Dendreon
Healthcare - Subsidiary
Mallinckrodt Pharmaceuticals
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top